Ribosome-mediated biosynthesis of pyridazinone oligomers in vitro

Abstract

The ribosome is a macromolecular machine that catalyzes the sequence-defined polymerization of L-α-amino acids into polypeptides. The catalysis of peptide bond formation between amino acid substrates is based on entropy trapping, wherein the adjacency of transfer RNA (tRNA)-coupled acyl bonds in the P-site and the α-amino groups in the A-site aligns the substrates for coupling. The plasticity of this catalytic mechanism has been observed in both remnants of the evolution of the genetic code and modern efforts to reprogram the genetic code (e.g., ribosomal incorporation of non-canonical amino acids, ribosomal ester formation). However, the limits of ribosome-mediated polymerization are underexplored. Here, rather than peptide bonds, we demonstrate ribosome-mediated polymerization of pyridazinone bonds via a cyclocondensation reaction between activated γ-keto and α-hydrazino ester monomers. In addition, we demonstrate the ribosome-catalyzed synthesis of peptide-hybrid oligomers composed of multiple sequence-defined alternating pyridazinone linkages. Our results highlight the plasticity of the ribosome’s ancient bond-formation mechanism, expand the range of non-canonical polymeric backbones that can be synthesized by the ribosome, and open the door to new applications in synthetic biology.

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 24, 2022
Source ID
10.1038/s41467-022-33701-2

Entities

People

  • Andrew D Ellington
  • Brandon M. Hosford
  • Camila Kofman
  • Do Soon Kim
  • Eric Anslyn
  • Jaime Coronado
  • Jeffrey S. Moore
  • Jongdoo Lim
  • Joongoo Lee
  • Michael C Jewett
  • Namjin Cho
  • Sangwon Seo

Organizations

  • Army Research Office
  • National Institute of General Medical Sciences
  • National Research Foundation of Korea

Tags

Fields of Study

  • Chemistry

Readers

  • Cellular and Molecular Pathways of Apoptosis.
  • Organic Chemistry

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech